Skip to content
Embassy Group clocks revenue of Rs 1,370 crore in FY23, up by 210 percent

Embassy Group clocks revenue of Rs 1,370 crore in FY23, up by 210 percent

The company plans to launch at least four new residential projects in FY24, with a development potential of 5 million square feet and an expected gross revenue of over Rs 3,000 crore.

Read More

​ The company plans to launch at least four new residential projects in FY24, with a development potential of 5 million square feet and an expected gross revenue of over Rs 3,000 crore. The company plans to launch at least four new residential projects in FY24, with a development potential of 5 million square feet and an expected gross revenue of over Rs 3,000 crore.  Moneycontrol Latest News Read More  

The company plans to launch at least four new residential projects in FY24, with a development potential of 5 million square feet and an expected gross revenue of over Rs 3,000 crore.

Centre meets FY23 fiscal deficit target of 6.4% of GDP

Centre meets FY23 fiscal deficit target of 6.4% of GDP

In absolute terms, the central government#39;s fiscal deficit in 2022-23 was Rs 17.33 lakh crore as against the revised estimate of Rs 17.55 lakh crore.

Read More

​ In absolute terms, the central government#39;s fiscal deficit in 2022-23 was Rs 17.33 lakh crore as against the revised estimate of Rs 17.55 lakh crore. In absolute terms, the central government#39;s fiscal deficit in 2022-23 was Rs 17.33 lakh crore as against the revised estimate of Rs 17.55 lakh crore.  Moneycontrol Latest News Read More  

In absolute terms, the central government#39;s fiscal deficit in 2022-23 was Rs 17.33 lakh crore as against the revised estimate of Rs 17.55 lakh crore.

Gainers  Losers: 10 stocks that moved the most on May 31

Gainers Losers: 10 stocks that moved the most on May 31

The Sensex was down 346.89 points or 0.55 percent at 62,622.24, and the Nifty was down 99.40 points or 0.53 percent at 18,534.40. About 1,679 shares advanced, 1,733 shares declined, and 133 shares were unchanged.

Read More

​ The Sensex was down 346.89 points or 0.55 percent at 62,622.24, and the Nifty was down 99.40 points or 0.53 percent at 18,534.40. About 1,679 shares advanced, 1,733 shares declined, and 133 shares were unchanged. The Sensex was down 346.89 points or 0.55 percent at 62,622.24, and the Nifty was down 99.40 points or 0.53 percent at 18,534.40. About 1,679 shares advanced, 1,733 shares declined, and 133 shares were unchanged.  Moneycontrol Latest News Read More  

The Sensex was down 346.89 points or 0.55 percent at 62,622.24, and the Nifty was down 99.40 points or 0.53 percent at 18,534.40. About 1,679 shares advanced, 1,733 shares declined, and 133 shares were unchanged.

Mumbai’s May property registrations down three percent on year, 9 percent on month: Maharashtra govt data

Mumbai’s May property registrations down three percent on year, 9 percent on month: Maharashtra govt data

According to the data, property in the Rs 1 crore bracket had 48 percent of share in the property registrations followed by 37 percent in Rs 1 crore to Rs 2.5 crore range.

Read More

​ According to the data, property in the Rs 1 crore bracket had 48 percent of share in the property registrations followed by 37 percent in Rs 1 crore to Rs 2.5 crore range. According to the data, property in the Rs 1 crore bracket had 48 percent of share in the property registrations followed by 37 percent in Rs 1 crore to Rs 2.5 crore range.  Moneycontrol Latest News Read More  

According to the data, property in the Rs 1 crore bracket had 48 percent of share in the property registrations followed by 37 percent in Rs 1 crore to Rs 2.5 crore range.

Neutral Aurobindo Pharma; target of Rs 600: Motilal Oswal

Neutral Aurobindo Pharma; target of Rs 600: Motilal Oswal

Motilal Oswal recommended Neutral rating on Aurobindo Pharma with a target price of Rs 600 in its research report dated May 29, 2023.

Read More

​ Motilal Oswal recommended Neutral rating on Aurobindo Pharma with a target price of Rs 600 in its research report dated May 29, 2023. Motilal Oswal recommended Neutral rating on Aurobindo Pharma with a target price of Rs 600 in its research report dated May 29, 2023.  Moneycontrol Latest News Read More  

Motilal Oswal recommended Neutral rating on Aurobindo Pharma with a target price of Rs 600 in its research report dated May 29, 2023.

Neutral Repco Home Finance; target of Rs 255: Motilal Oswal

Neutral Repco Home Finance; target of Rs 255: Motilal Oswal

Motilal Oswal recommended Neutral rating on Repco Home Finance with a target price of Rs 255 in its research report dated May 30, 2023.

Read More

​ Motilal Oswal recommended Neutral rating on Repco Home Finance with a target price of Rs 255 in its research report dated May 30, 2023. Motilal Oswal recommended Neutral rating on Repco Home Finance with a target price of Rs 255 in its research report dated May 30, 2023.  Moneycontrol Latest News Read More  

Motilal Oswal recommended Neutral rating on Repco Home Finance with a target price of Rs 255 in its research report dated May 30, 2023.

Neutral Balkrishna Industries; target of Rs 2100: Motilal Oswal

Neutral Balkrishna Industries; target of Rs 2100: Motilal Oswal

Motilal Oswal recommended Neutral rating on Balkrishna Industries with a target price of Rs 2100 in its research report dated May 30, 2023.

Read More

​ Motilal Oswal recommended Neutral rating on Balkrishna Industries with a target price of Rs 2100 in its research report dated May 30, 2023. Motilal Oswal recommended Neutral rating on Balkrishna Industries with a target price of Rs 2100 in its research report dated May 30, 2023.  Moneycontrol Latest News Read More  

Motilal Oswal recommended Neutral rating on Balkrishna Industries with a target price of Rs 2100 in its research report dated May 30, 2023.

en_USEnglish